Advertisement

Topics

Long-term metformin therapy reduces CVD risk in type 1 diabetes

11:30 EDT 15 Jun 2017 | Healio

SAN DIEGO — Middle-aged adults with long-standing type 1 diabetes at high risk for cardiovascular disease who added metformin to insulin therapy for 3 years saw reductions in body weight, LDL cholesterol and atherosclerosis progression vs. those assigned placebo, according to a speaker here. “Type 1 diabetes is associated with reduced life expectancy by 11 to 13 years due to heart disease and stroke,” John Petrie, MD, PhD, professor of diabetic medicine at the University of Glasgow in Scotland, said during a press conference discussing the findings. “Metformin is an inexpensive agent widely used to reduce heart disease in type 2 diabetes, so we hypothesized that it might have similar effects in type 1 [diabetes].”

Original Article: Long-term metformin therapy reduces CVD risk in type 1 diabetes

NEXT ARTICLE

More From BioPortfolio on "Long-term metformin therapy reduces CVD risk in type 1 diabetes"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...